FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Biotech IPO | Aryx Therapeutics

SPOTLIGHT: ARYx slashes IPO price

Tools

ARYx Therapeutics (a 2004 Fierce 15 company) raised $50 million in its IPO after slashing its price from a forecasted $14 to $16 a share down to $10. Report

More stories about Biotech IPO   Aryx Therapeutics  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.